Embecta is dedicated to enhancing the lives of individuals living with diabetes through a range of innovative insulin delivery products and educational resources. Their offerings include a variety of pen needles, such as the BD Nano™ and BD Ultra-Fine™ series, which are designed with patient comfort in mind and come in multiple lengths to accommodate different injection needs. Additionally, Embecta provides a comprehensive portfolio of insulin syringes that cater to diverse patient preferences, ensuring that users can find the right fit for their specific requirements. This focus on personalization reflects their commitment to making diabetes management simpler and more effective for everyone.

In addition to their product offerings, Embecta has developed the embassador™ Companion 24/7, a digital platform that provides users with educational content, personalized health management tools, and diabetes-friendly recipes. This resource aims to empower individuals by equipping them with the knowledge and tools necessary for effective diabetes care. Furthermore, Embecta emphasizes the importance of accessories, such as alcohol swabs, to support safe and hygienic injection practices. Through these technologies and resources, Embecta strives to create a supportive environment for those managing diabetes, reinforcing their mission to help people live a life unlimited by the condition.

United States

At embecta (formerly part of BD), we are singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of developing and providing solutions to the diabetes community, today, we are a global medical technology company and leader in insulin delivery devices. More than 30 million people in over 100 countries rely on our pen needle and syringe products every day.  

BD is the manufacturer of the advertised products.  

Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement 

Embecta

Company Details